Portfolio (Quarterly)
Guide ↗
Propel Bio Management, LLC
· CIK 0001969764| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CORT | CORCEPT THERAPEUTICS INC | Healthcare | 147,828.0 | $6.0M | 3.80% | NEW | — | $40.74 | +120.2% |
| 2 | VOR | VOR BIOPHARMA INC | Healthcare | 314,543.0 | $5.6M | 3.52% | NEW | — | $17.76 | -2.4% |
| 3 | OBIO | ORCHESTRA BIOMED HLDGS INC | Healthcare | 896,701.0 | $3.8M | 2.41% | NEW | — | $4.27 | -12.9% |
| 4 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 380,420.0 | $3.6M | 2.26% | NEW | — | $9.41 | +15.2% |
| 5 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 382,375.0 | $3.2M | 2.03% | NEW | — | $8.44 | +8.6% |
| 6 | — | UPSTREAM BIO INC | — | 341,779.0 | $3.1M | 1.95% | NEW | — | $9.07 | — |
| 7 | AQST | AQUESTIVE THERAPEUTICS INC | Healthcare | 710,988.0 | $3.0M | 1.86% | NEW | — | $4.15 | -5.1% |
| 8 | EYPT | EYEPOINT INC | Healthcare | 215,825.0 | $2.8M | 1.76% | NEW | — | $12.92 | +0.9% |
| 9 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 223,802.0 | $2.6M | 1.67% | NEW | — | $11.83 | +46.8% |
| 10 | — | IMMUNIC INC | — | 2,344,779.0 | $2.6M | 1.65% | NEW | — | $1.12 | — |
| 11 | CHRS | COHERUS ONCOLOGY INC | Healthcare | 1,420,550.0 | $2.4M | 1.52% | NEW | — | $1.70 | -18.2% |
| 12 | OVID | OVID THERAPEUTICS INC | Healthcare | 921,457.0 | $2.0M | 1.28% | NEW | — | $2.21 | +10.8% |
| 13 | — | PALISADE BIO INC | — | 1,115,000.0 | $2.0M | 1.26% | NEW | — | $1.79 | — |
| 14 | QURE | UNIQURE NV | Healthcare | 104,772.0 | $1.7M | 1.08% | NEW | — | $16.35 | +140.7% |
| 15 | NUVB | NUVATION BIO INC | Healthcare | 329,296.0 | $1.4M | 0.89% | NEW | — | $4.29 | +31.5% |
| 16 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 43,798.0 | $1.3M | 0.82% | NEW | — | $29.85 | -9.0% |
| 17 | EVMN | EVOMMUNE INC | Healthcare | 55,664.0 | $1.3M | 0.81% | NEW | — | $22.99 | -49.1% |
| 18 | CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | 85,791.0 | $1.3M | 0.79% | NEW | — | $14.58 | -2.1% |
| 19 | ALDX | ALDEYRA THERAPEUTICS INC | Healthcare | 730,606.0 | $1.2M | 0.78% | NEW | — | $1.69 | +1.8% |
| 20 | — | ARTIVA BIOTHERAPEUTICS INC | — | 146,369.0 | $950K | 0.60% | NEW | — | $6.49 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
75.4%
Energy
24.6%